Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kauffman Michael
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   800,347    

Indirect Shares

   898,131      
Direct Value   $920,732    

Indirect Value

   $961,000      
Total Shares   1,698,478      
Total Value   $1,881,732      


Onyx Pharmaceuticals Inc $0 Karyopharm Therapeutics Inc. $763,720 Verastem, Inc. $95,360 Kezar Life Sciences, Inc. $52,035 Adicet Bio, Inc $9,617 Onyx Pharmaceuticals Inc $0 Karyopharm Therapeutics Inc. $763,720 Verastem, Inc. $95,360 Kezar Life Sciences, Inc. $52,035 Adicet Bio, Inc $9,617
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    12    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    12    
   
     Gain/Loss Ratio :
   0.0   
   -12.0   
     Percentage Gain/Loss :
     0.0%
 -553.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Onyx Pharmaceuticals Inc ONXX Chief Medical Officer 2010-02-09 9,000 2009-11-16 0    Premium*  
            Karyopharm Therapeutics Inc. KPTI Director 2022-02-28 713,757 2022-02-28 898,131    Premium*  
            Verastem, Inc. VSTM Director 2018-09-28 8,000 2014-09-17 0    Premium*  
            Kezar Life Sciences, Inc. KZR Director 2022-01-03 63,690 2018-06-25 0    Premium*  
            Adicet Bio, Inc ACET Director 2023-06-01 5,900 2023-06-01 0    Premium*  
* Premium Members only  

Records found :    156         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ACET Adicet Bio, Inc Director   –       •      –    2023-06-01 4 A $0.00 $0 D/D 5,900 5,900 0 -
KPTI Karyopharm Therapeutics I... President, C.E.O., C.M.O.Offic   •       •      –    2013-11-05 3 IO $0.00 $0 D/D 0 620,771 -
KPTI Karyopharm Therapeutics I... President, C.E.O., C.M.O.Offic   •       •      –    2013-11-05 3 IO $0.00 $0 I/I 0 1,001,713 -
KPTI Karyopharm Therapeutics I... President, CEO & CMO   •       •      –    2013-11-12 4 A $0.00 $0 D/D 132,575 753,346 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2013-12-20 5 GD $0.00 $0 I/I 82,750 918,963 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2013-12-20 5 GD $0.00 $0 D/D 55,750 697,596 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2014-06-17 4 AS $40.36 $403,635 I/I (10,000) 908,963 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2014-06-18 4 AS $43.15 $431,523 D/D (10,000) 687,596 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2014-07-02 4 S $42.50 $4,250,000 I/I (100,000) 808,963 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2014-07-02 4 S $42.50 $4,250,000 D/D (100,000) 587,596 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2014-12-01 4 GD $0.00 $0 I/I 20,000 788,963 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2015-01-12 4 S $33.00 $825,000 D/D (25,000) 562,596 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2015-01-12 4 S $33.00 $825,000 I/I (25,000) 763,963 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2015-12-30 5 GD $0.00 $0 I/I 3,144 760,819 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2015-12-30 5 GD $0.00 $0 D/D 3,144 559,452 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2017-12-07 4 AS $10.39 $103,903 I/I (10,000) 713,510 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2017-12-07 4 OE $0.26 $2,640 I/I 10,000 723,510 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2017-12-18 4 AS $9.16 $91,553 D/D (10,000) 512,143 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2017-12-18 4 OE $0.26 $2,640 D/D 10,000 522,143 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2018-01-08 4 AS $10.08 $100,769 I/I (10,000) 713,510 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2018-01-08 4 OE $0.26 $2,640 I/I 10,000 723,510 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2018-01-18 4 AS $10.09 $100,882 D/D (10,000) 512,143 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2018-01-18 4 OE $0.26 $2,640 D/D 10,000 522,143 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2018-02-07 4 AS $12.50 $125,048 I/I (10,000) 713,510 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2018-02-07 4 OE $0.26 $2,640 I/I 10,000 723,510 0 -
  156  Records found
  1  2   3   4   5   6   7      
  Page 1 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us